Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pleural Malignant Mesothelioma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02399371
What this trial is testing

Pembrolizumab in Treating Patients With Malignant Mesothelioma

Who this might be right for
Biphasic MesotheliomaEpithelioid MesotheliomaPeritoneal Malignant Mesothelioma+7 more
University of Chicago 65
Early research (Phase 1)Study completedNCT00019825
What this trial is testing

Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura

Who this might be right for
Esophageal CancerLung CancerMalignant Mesothelioma+1 more
National Cancer Institute (NCI)
Early research (Phase 1)Looking for participantsNCT06726564
What this trial is testing

MT027 in Patients with Pleural Malignant Tumors

Who this might be right for
Advanced Malignant Solid TumorMalignant Pleural EffusionPleura Carcinoma+3 more
Suzhou Maximum Bio-tech Co., Ltd. 18
Testing effectiveness (Phase 2)Looking for participantsNCT06051695
What this trial is testing

Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

Who this might be right for
Solid Tumor, AdultColorectal CancerNSCLC+17 more
A2 Biotherapeutics Inc. 474
Early research (Phase 1)Study completedNCT03507452
What this trial is testing

First-in-human Study of BAY2287411 Injection, a Thorium-227 Labeled Antibody-chelator Conjugate, in Patients With Tumors Known to Express Mesothelin

Who this might be right for
Advanced Recurrent Malignant Pleural Epithelioid MesotheliomaAdvanced Recurrent Malignant Peritoneal Epithelioid MesotheliomaAdvanced Recurrent Serous Ovarian Cancer+1 more
Bayer 36
Early research (Phase 1)Study completedNCT01675765
What this trial is testing

Safety and Efficacy of Listeria in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Aduro Biotech, Inc. 60
Testing effectiveness (Phase 2)Looking for participantsNCT05086692
What this trial is testing

A Beta-only IL-2 ImmunoTherapY Study

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more
Medicenna Therapeutics, Inc. 115
Testing effectiveness (Phase 2)Ended earlyNCT05714553
What this trial is testing

NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours

Who this might be right for
Advanced CancerAdvanced Solid TumorNeoplasm Malignant+14 more
NuCana plc 19
Early research (Phase 1)UnknownNCT03852823
What this trial is testing

Study of Recombinant Human Anti-PD-1 Monoclonal Antibody in Patients With Advanced Tumours

Who this might be right for
Advanced Solid TumoursCervical CancerMalignant Mesothelioma+2 more
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 192
Testing effectiveness (Phase 2)Ended earlyNCT04914897
What this trial is testing

SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Lung Cancer or Mesothelioma (Pegathor Lung 202)

Who this might be right for
Pleural MesotheliomaNon-small Cell Lung Cancer
Sanofi 106
Early research (Phase 1)Active Not RecruitingNCT04897022
What this trial is testing

Pembrolizumab and Radiation Therapy in People With Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Memorial Sloan Kettering Cancer Center 7
Large-scale testing (Phase 3)Study completedNCT00651456
What this trial is testing

Mesothelioma Avastin Plus Pemetrexed-cisplatin Study

Who this might be right for
Mesothelioma
Intergroupe Francophone de Cancerologie Thoracique 448
Testing effectiveness (Phase 2)Study completedNCT04480372
What this trial is testing

SAKK 17/18 (ORIGIN) MPM & NSCLC >1st Line Gemci & Atezo Ph II

Who this might be right for
Malignant Pleural MesotheliomaNon-small Cell Lung Cancer
Swiss Cancer Institute 68
Testing effectiveness (Phase 2)Study completedNCT02397928
What this trial is testing

Safety and Efficacy of TTFields (150 kHz) Concomitant With Pemetrexed and Cisplatin or Carboplatin in Malignant Pleural Mesothelioma (STELLAR)

Who this might be right for
Malignant Pleural Mesothelioma
NovoCure Ltd. 82
Testing effectiveness (Phase 2)Ended earlyNCT05563272
What this trial is testing

89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors

Who this might be right for
Cervical CancerColorectal CancerEsophageal Cancer+16 more
Telix Pharmaceuticals (Innovations) Pty Ltd 11
Testing effectiveness (Phase 2)Study completedNCT00513877
What this trial is testing

Bortezomib in Treating Patients With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Mesothelioma
Cancer Trials Ireland 33
Early research (Phase 1)Study completedNCT00299962
What this trial is testing

Gene Therapy for Pleural Malignancies

Who this might be right for
Pleural MesotheliomaMetastatic Pleural Effusions
University of Pennsylvania 17
Testing effectiveness (Phase 2)Ended earlyNCT00281125
What this trial is testing

Phase I/II Trial of PTK787 and Pemetrexed With or Without Cisplatin for Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer and Pleural Mesothelioma
Nevada Cancer Institute 20
Not applicableWithdrawnNCT02106559
What this trial is testing

Photodynamic Therapy During Surgery in Treating Patients With Pleural Malignancy

Who this might be right for
Stage III Malignant MesotheliomaStage IIIB Non-small Cell Lung CancerStage IV Malignant Mesothelioma+1 more
Ohio State University Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00738582
What this trial is testing

An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Morphotek 89
Next Page